Cell Kinetics logo

CKNTF - Cell Kinetics Share Price

$0.02 0.0  0.0%

Last Trade - 23/11/20

Sector
Healthcare
Size
Micro Cap
Market Cap £298k
Enterprise Value £1.71m
Revenue £15.7k
Position in Universe th / 6444
Bullish
Bearish
Unlock CKNTF Revenue
Momentum
Relative Strength (%)
1m +429%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -80.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2003 2004 2005 2006 2007 2008 2009E 2010E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.021
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2008, CellKinetics Ltd revenues increased from $0K to $21K. Net lossincreased 14% to $2.4M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Higher net loss reflectsResearch and development costs increase of 1% to $1.2M(expense). Basic Earnings per Share excluding ExtraordinaryItems increased from -$0.13 to -$0.12.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CKNTF Revenue Unlock CKNTF Revenue

Net Income

CKNTF Net Income Unlock CKNTF Revenue

Normalised EPS

CKNTF Normalised EPS Unlock CKNTF Revenue

PE Ratio Range

CKNTF PE Ratio Range Unlock CKNTF Revenue

Dividend Yield Range

CKNTF Dividend Yield Range Unlock CKNTF Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CKNTF EPS Forecasts Unlock CKNTF Revenue
Profile Summary

Cell Kinetics Limited is seeking to commercially exploit a growing need to study individual live cells, through the development, marketing and selling of an improved Cell carrier under the CKChip product line. The Cell Carrier can accommodate cells, each in individual wells, for measuring reactions of living cells while the cells are in a static state for a considerable period of time. The CKChip is a platform static cytometry technology that enables the simultaneous examination of many individual live cells using simple imaging methods such as fluorescence microscopy.

Directors
Last Annual December 31st, 2008
Last Interim January 1st, 1970
Incorporated May 23, 2002
Public Since February 11, 2008
No. of Shareholders: 98
No. of Employees: 10
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 19,999,961
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CKNTF Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CKNTF
Upcoming Events for CKNTF
Frequently Asked Questions for Cell Kinetics
What is the Cell Kinetics share price?

As of 23/11/20, shares in Cell Kinetics are trading at $0.02, giving the company a market capitalisation of £298k. This share price information is delayed by 15 minutes.

How has the Cell Kinetics share price performed this year?

Shares in Cell Kinetics are currently trading at $0.02 and the price has moved by 0.770k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cell Kinetics price has moved by 0.662k% over the past year.

What are the analyst and broker recommendations for Cell Kinetics?

There are no analysts currently covering Cell Kinetics.

When will Cell Kinetics next release its financial results?

It is not known when Cell Kinetics will next release financial results.

What is the Cell Kinetics dividend yield?

Cell Kinetics does not currently pay a dividend.

Does Cell Kinetics pay a dividend?

Cell Kinetics does not currently pay a dividend.

When does Cell Kinetics next pay dividends?

Cell Kinetics does not currently pay a dividend.

How do I buy Cell Kinetics shares?

To buy shares in Cell Kinetics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cell Kinetics?

Shares in Cell Kinetics are currently trading at $0.02, giving the company a market capitalisation of £298k.

Where are Cell Kinetics shares listed? Where are Cell Kinetics shares listed?

Here are the trading details for Cell Kinetics:

Country of listing: United States
Exchange: PNK
Ticker Symbol: CKNTF
What kind of share is Cell Kinetics?

We were not able to load our ranking data for Cell Kinetics

Is there a Cell Kinetics share price forecast 2020?

We were not able to load any forecast data for Cell Kinetics.

How can I tell whether the Cell Kinetics share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cell Kinetics. Over the past six months, the relative strength of its shares against the market has been -56.48%. At the current price of $0.02, shares in Cell Kinetics are trading at 0.203k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cell Kinetics PE Ratio?

We were not able to find PE ratio data for Cell Kinetics.

Who are the key directors of Cell Kinetics?

Cell Kinetics's management team is headed by:

Asaf Ben-Arye - CEO
Mitchell Freeman - DRC
Daniel Luchansky - DRC
Shmuel Peretz - CHM
Stephen Crea - CAO
Lauri Hanover - DRC
David Arie - DRC
Jaclynn Shweky - DRC
Who are the major shareholders of Cell Kinetics?

Here are the top five shareholders of Cell Kinetics based on the size of their shareholding:

XR Securities LLC Investment Advisor
Percentage owned: 0.25% (49.3k shares)
Taylor Wealth Management Partners LLC Investment Advisor
Percentage owned: % (n/a shares)
Similar to CKNTF
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.